Sign In
Buy DNA
$7.89
-0.110 (-1.38%)
At Close: Jun 12, 2026
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today shared updates on the company's oncology pipeline and focused approach to the research and development of po
3 Sorry Biotech Stocks to Sell in May While You Still Can
07:00am, Friday, 31'st May 2024
Morgan Stanley recently released its bullish take on the biotech space, driven by anticipated interest rate cuts and a surge in mergers and acquisitions (M&A) activity. The analyst firm states biotech
Ginkgo Bioworks Stock: Bull vs. Bear
05:47am, Friday, 31'st May 2024
Ginkgo is embarking on a cost-cutting plan that could pave the path to profitability and share performance. The main bear case against Ginkgo is there's no compelling reason to buy the stock right now
Should You Buy the Dip on Ginkgo Bioworks Stock?
06:30am, Thursday, 30'th May 2024
Ginkgo Bioworks is still struggling with operating efficiency. Management is signaling that its processes may be streamlined.
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine
04:05pm, Wednesday, 29'th May 2024
QIAseq Multimodal DNA/RNA Lib Kit enables streamlined DNA and RNA library preparation for next-generation sequencing from a single sample // New kit advances precision medicine by facilitating multiom
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
06:00am, Wednesday, 29'th May 2024
Cathie Wood likes to invest in risky biotech stocks. Ginkgo Bioworks has ambitions to disrupt biopharma manufacturing.
Integrated DNA Technologies Invests in New U.S. Synthetic Biology Manufacturing Facility
08:55am, Tuesday, 28'th May 2024
CORALVILLE, Iowa--(BUSINESS WIRE)-- #AdvancesinSyntheticBiology--IDT's newly expanded U.S. manufacturing site provides a growth runway for manufacturing of synthetic biology products to support growin
3 Things You Need to Know if You Buy Ginkgo Bioworks Today
08:30am, Saturday, 25'th May 2024
Ginkgo Bioworks is using a unique approach to laboratory automation. It's also spending a lot of its finite supply of money on this endeavor.
Down 72%. Is Ginkgo Bioworks a Buy on the Dip?
04:57am, Saturday, 25'th May 2024
Shares of Ginkgo Bioworks have been beaten severely in response to heavy financial losses. The company's cell foundry could disrupt the biopharmaceutical manufacturing industry.
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
12:40pm, Monday, 20'th May 2024
Ginkgo Bioworks reported a steep fall in revenue but lower losses earlier this month. Losses mainly shrank due to cuts in workforce and research and development; not good signs for a growth stock.
Ark Investment Management, led by star investor Cathie Wood, is facing a harsh reality in 2024. While the broader market is hitting record highs, Ark’s actively managed funds are lagging far behind,
National Bank of Canada FI Has $51,000 Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
05:04am, Monday, 20'th May 2024
National Bank of Canada FI raised its position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 142.0% during the fourth quarter, according to the company in its most recent 13F fil
TOKYO--(BUSINESS WIRE)--Helical Fusion hat im März 2024 eine Partnerschaftsvereinbarung mit dem National Institute for Fusion Science (NIFS) geschlossen. Das NIFS hat die „HF Collaboration Research
Q2 2024 Earnings Estimate for Precision BioSciences, Inc. (NASDAQ:DTIL) Issued By HC Wainwright
01:38am, Monday, 20'th May 2024
Precision BioSciences, Inc. (NASDAQ:DTIL – Free Report) – Research analysts at HC Wainwright raised their Q2 2024 earnings estimates for shares of Precision BioSciences in a note issued to
Is Ginkgo Bioworks Holdings Stock a Buy?
02:38pm, Saturday, 18'th May 2024
Ginkgo Bioworks has been focusing on developing its artificial intelligence capabilities to enhance its cell programming platform. The company's results, however, have been underwhelming, with sales f
